{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:33:51Z","timestamp":1777700031340,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,9]]},"DOI":"10.7759\/cureus.66494","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T10:55:42Z","timestamp":1723200942000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of MicroRNA 145 and MicroRNA 155 as Markers of Cardiovascular Risk in Chronic Kidney Disease"],"prefix":"10.7759","author":[{"given":"Amit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Priyadarshini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreejith","family":"Parameswaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananthakrishnan","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medha","family":"Rajappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.08.009","article-title":"CKD-mineral and bone disorder: core curriculum 2011","volume":"58","author":"Moorthi RN","year":"2011","unstructured":"Moorthi RN, Moe SM. CKD-mineral and bone disorder: core curriculum 2011. Am J Kidney Dis. 2011, 58:1022-36. 10.1053\/j.ajkd.2011.08.009","journal-title":"Am J Kidney Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group: KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011). 2017, 7:1-59. 10.1016\/j.kisu.2017.04.001","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher J","year":"2001","unstructured":"Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001, 38:938-42. 10.1161\/hy1001.096358","journal-title":"Hypertension"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000486743","article-title":"Association of circulating levels of ADMA with carotid intima-media thickness in patients with CKD: a systematic review and meta-analysis","volume":"43","author":"Wang F","year":"2018","unstructured":"Wang F, Xiong R, Feng S, Lu X, Li H, Wang S. Association of circulating levels of ADMA with carotid intima-media thickness in patients with CKD: a systematic review and meta-analysis. Kidney Blood Press Res. 2018, 43:25-33. 10.1159\/000486743","journal-title":"Kidney Blood Press Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12811216","article-title":"Endothelium-dependent and -independent vascular function in advanced chronic kidney disease","volume":"12","author":"Kopel T","year":"2017","unstructured":"Kopel T, Kaufman JS, Hamburg N, Sampalis JS, Vita JA, Dember LM. Endothelium-dependent and -independent vascular function in advanced chronic kidney disease. Clin J Am Soc Nephrol. 2017, 12:1588-94. 10.2215\/CJN.12811216","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","article-title":"Endothelial dysfunction by flow-mediated vasodilatation in chronic kidney disease","volume":"63","author":"Shukla V","year":"2015","unstructured":"Shukla V, Dey R, Chandra A, Karoli R, Khanduri S. Endothelial dysfunction by flow-mediated vasodilatation in chronic kidney disease. J Assoc Physicians India. 2015, 63:30-3.","journal-title":"J Assoc Physicians India"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2019.01.002","article-title":"miR-223 and other miRNA's evaluation in chronic kidney disease: innovative biomarkers and therapeutic tools","volume":"4","author":"Metzinger-Le Meuth V","year":"2019","unstructured":"Metzinger-Le Meuth V, Metzinger L. miR-223 and other miRNA's evaluation in chronic kidney disease: innovative biomarkers and therapeutic tools. Noncoding RNA Res. 2019, 4:30-5. 10.1016\/j.ncrna.2019.01.002","journal-title":"Noncoding RNA Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00163.2014","article-title":"A current understanding of vascular calcification in CKD","volume":"307","author":"Paloian NJ","year":"2014","unstructured":"Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol. 2014, 307:F891-900. 10.1152\/ajprenal.00163.2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2013.10.005","article-title":"Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease","volume":"1842","author":"Ta\u00efbi F","year":"2014","unstructured":"Ta\u00efbi F, Metzinger-Le Meuth V, M'Baya-Moutoula E, et al.. Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease. Biochim Biophys Acta. 2014, 1842:88-98. 10.1016\/j.bbadis.2013.10.005","journal-title":"Biochim Biophys Acta"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2014.03.009","article-title":"The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a\/b-3p in human atherosclerotic coronary artery","volume":"23","author":"Hao L","year":"2014","unstructured":"Hao L, Wang XG, Cheng JD, et al.. The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a\/b-3p in human atherosclerotic coronary artery. Cardiovasc Pathol. 2014, 23:217-23. 10.1016\/j.carpath.2014.03.009","journal-title":"Cardiovasc Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000500923","article-title":"microRNA-145 involves in the pathogenesis of renal vascular lesions and may become a potential therapeutic target in patients with juvenile lupus nephritis","volume":"44","author":"Cai Z","year":"2019","unstructured":"Cai Z, Xiang W, Peng X, Ding Y, Liao W, He X. microRNA-145 involves in the pathogenesis of renal vascular lesions and may become a potential therapeutic target in patients with juvenile lupus nephritis. Kidney Blood Press Res. 2019, 44:643-55. 10.1159\/000500923","journal-title":"Kidney Blood Press Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.197517","article-title":"MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation","volume":"105","author":"Cheng Y","year":"2009","unstructured":"Cheng Y, Liu X, Yang J, et al.. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 2009, 105:158-66. 10.1161\/CIRCRESAHA.109.197517","journal-title":"Circ Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9869208","article-title":"The emerging role of microRNA-155 in cardiovascular diseases","volume":"2016","author":"Cao RY","year":"2016","unstructured":"Cao RY, Li Q, Miao Y, et al.. The emerging role of microRNA-155 in cardiovascular diseases. Biomed Res Int. 2016, 2016:9869208. 10.1155\/2016\/9869208","journal-title":"Biomed Res Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.08.067","article-title":"MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts","volume":"400","author":"Zheng L","year":"2010","unstructured":"Zheng L, Xu CC, Chen WD, et al.. MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts. Biochem Biophys Res Commun. 2010, 400:483-8. 10.1016\/j.bbrc.2010.08.067","journal-title":"Biochem Biophys Res Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.04.014","article-title":"Serum phosphorus and risk of cardiovascular disease, all-cause mortality, or graft failure in kidney transplant recipients: an ancillary study of the Favorit trial cohort","volume":"70","author":"Merhi B","year":"2017","unstructured":"Merhi B, Shireman T, Carpenter MA, et al.. Serum phosphorus and risk of cardiovascular disease, all-cause mortality, or graft failure in kidney transplant recipients: an ancillary study of the Favorit trial cohort. Am J Kidney Dis. 2017, 70:377-85. 10.1053\/j.ajkd.2017.04.014","journal-title":"Am J Kidney Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02484-0","article-title":"Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients","volume":"52","author":"Ashokachakkaravarthy K","year":"2020","unstructured":"Ashokachakkaravarthy K, Rajappa M, Parameswaran S, et al.. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients. Int Urol Nephrol. 2020, 52:1321-8. 10.1007\/s11255-020-02484-0","journal-title":"Int Urol Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064558","article-title":"Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD)","volume":"8","author":"Chen NX","year":"2013","unstructured":"Chen NX, Kiattisunthorn K, O'Neill KD, et al.. Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One. 2013, 8:e64558. 10.1371\/journal.pone.0064558","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey AS","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150:604-12. 10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.167015","article-title":"Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?","volume":"57","author":"Green DJ","year":"2011","unstructured":"Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G. Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?. Hypertension. 2011, 57:363-9. 10.1161\/HYPERTENSIONAHA.110.167015","journal-title":"Hypertension"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26121","article-title":"Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification","volume":"233","author":"Fakhry M","year":"2018","unstructured":"Fakhry M, Skafi N, Fayyad-Kazan M, et al.. Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification. J Cell Physiol. 2018, 233:4056-67. 10.1002\/jcp.26121","journal-title":"J Cell Physiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13532","article-title":"Borderline high serum calcium levels are associated with arterial stiffness and 10-year cardiovascular disease risk determined by Framingham risk score","volume":"21","author":"Park B","year":"2019","unstructured":"Park B, Lee YJ. Borderline high serum calcium levels are associated with arterial stiffness and 10-year cardiovascular disease risk determined by Framingham risk score. J Clin Hypertens (Greenwich). 2019, 21:668-73. 10.1111\/jch.13532","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074996","article-title":"Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study","volume":"8","author":"McGovern AP","year":"2013","unstructured":"McGovern AP, de Lusignan S, van Vlymen J, et al.. Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study. PLoS One. 2013, 8:e74996. 10.1371\/journal.pone.0074996","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.28.3.557","article-title":"Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke","volume":"28","author":"Wannamethee SG","year":"1997","unstructured":"Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke. 1997, 28:557-63. 10.1161\/01.str.28.3.557","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-010-9897-2","article-title":"Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease","volume":"44","author":"Lishmanov A","year":"2012","unstructured":"Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A. Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol. 2012, 44:541-7. 10.1007\/s11255-010-9897-2","journal-title":"Int Urol Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.61911","article-title":"Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients","volume":"12","author":"C\u0103pu\u015fa C","year":"2016","unstructured":"C\u0103pu\u015fa C, Stefan G, Stancu S, Ilyes A, Doroban\u0163u N, Mircescu G. Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients. Arch Med Sci. 2016, 12:1015-22. 10.5114\/aoms.2016.61911","journal-title":"Arch Med Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-879x2012007500165","article-title":"Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease","volume":"45","author":"Wang H","year":"2012","unstructured":"Wang H, Peng W, Shen X, Huang Y, Ouyang X, Dai Y. Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease. Braz J Med Biol Res. 2012, 45:1308-14. 10.1590\/s0100-879x2012007500165","journal-title":"Braz J Med Biol Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.12.024","article-title":"Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration","volume":"215","author":"Zhu N","year":"2011","unstructured":"Zhu N, Zhang D, Chen S, et al.. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis. 2011, 215:286-93. 10.1016\/j.atherosclerosis.2010.12.024","journal-title":"Atherosclerosis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2181","article-title":"MicroRNA-155 modulates the proliferation of vascular smooth muscle cells by targeting endothelial nitric oxide synthase","volume":"35","author":"Zhang J","year":"2015","unstructured":"Zhang J, Zhao F, Yu X, Lu X, Zheng G. MicroRNA-155 modulates the proliferation of vascular smooth muscle cells by targeting endothelial nitric oxide synthase. Int J Mol Med. 2015, 35:1708-14. 10.3892\/ijmm.2015.2181","journal-title":"Int J Mol Med"},{"key":"ref29","article-title":"Plasma asymmetric dimethylarginine and its association with some of cardiovascular disease risk factors in chronic kidney disease","volume":"74","author":"Quoc Hoang TA","year":"2019","unstructured":"Quoc Hoang TA, Tam V, Thang HV. Plasma asymmetric dimethylarginine and its association with some of cardiovascular disease risk factors in chronic kidney disease. Med J Malaysia. 2019, 74:209-14.","journal-title":"Med J Malaysia"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00603.2016","article-title":"Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease","volume":"312","author":"Downey RM","year":"2017","unstructured":"Downey RM, Liao P, Millson EC, Quyyumi AA, Sher S, Park J. Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease. Am J Physiol Renal Physiol. 2017, 312:F917-24. 10.1152\/ajprenal.00603.2016","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/221381-evaluation-of-microrna-145-and-microrna-155-as-markers-of-cardiovascular-risk-in-chronic-kidney-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T10:55:46Z","timestamp":1723200946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/221381-evaluation-of-microrna-145-and-microrna-155-as-markers-of-cardiovascular-risk-in-chronic-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.66494","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,9]]}}}